Expert panel rates state monopoly as the most effective cannabis policy for reducing youth use, excessive use, and impaired driving
A panel of nine substance use policy experts rated state monopoly over cannabis production and retail as the most effective policy for reducing youth use, excessive use, and impaired driving, while noting that almost no direct evidence exists for most cannabis policies.
Quick Facts
What This Study Found
State monopoly (government-owned production through retail) was rated most effective across all three outcome areas. Restrictions on retail availability, taxes, price restrictions, and retail operations restrictions were also highly rated. Policies targeting businesses were judged more effective than those targeting consumers. Experts reported little or no direct evidence from cannabis literature for most policies.
Key Numbers
9 panelists rated 18 policies across 3 outcomes. State monopoly ranked #1 for all three outcomes. A small number of policies were rated highly effective across all domains.
How They Did This
Modified Delphi approach with nine panelists (researchers and policy consultants) rating 18 cannabis policies on their theoretical efficacy for reducing youth use, excessive adult use, and cannabis-impaired driving using Likert scales.
Why This Research Matters
As more jurisdictions legalize cannabis, this expert consensus identifies which regulatory approaches are theoretically most promising while frankly acknowledging the almost complete absence of direct evidence.
The Bigger Picture
The finding that supply-side regulations (business-focused) are rated more effective than demand-side policies (consumer-focused) parallels lessons from alcohol and tobacco policy, where restricting commercial availability has consistently outperformed individual-level interventions.
What This Study Doesn't Tell Us
Expert opinion, not empirical evidence. Only nine panelists. Ratings are theoretical since most policies have not been empirically evaluated. U.S.-focused panel may not reflect international perspectives.
Questions This Raises
- ?Will any U.S. state adopt a cannabis monopoly model?
- ?Can these theoretical ratings be validated with real-world outcomes data?
- ?Do political realities make the most effective policies impractical?
Trust & Context
- Key Stat:
- State monopoly rated #1 across all three public health outcomes
- Evidence Grade:
- Expert panel consensus using modified Delphi method. Theoretical ratings, not empirical evidence.
- Study Age:
- Published in 2022.
- Original Title:
- Rating the comparative efficacy of state-level cannabis policies on recreational cannabis markets in the United States.
- Published In:
- The International journal on drug policy, 106, 103744 (2022)
- Authors:
- Blanchette, Jason G, Pacula, Rosalie Liccardo(18), Smart, Rosanna(5), Lira, Marlene C, Boustead, Anne E, Caulkins, Jonathan P, Kilmer, Beau, Kerr, William C, Treffers, Ryan, Naimi, Timothy S
- Database ID:
- RTHC-03716
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What type of cannabis policy did experts consider most effective?
State monopoly, where the government owns all production, manufacturing, wholesale, and retail operations, was rated the single most effective policy for reducing youth use, excessive use by adults, and impaired driving.
Is there direct evidence that these policies work?
Surprisingly, no. The panelists themselves reported that there is little or no direct evidence from the cannabis policy literature for most of the 18 policies they rated, highlighting a major research gap.
Read More on RethinkTHC
Cite This Study
https://rethinkthc.com/research/RTHC-03716APA
Blanchette, Jason G; Pacula, Rosalie Liccardo; Smart, Rosanna; Lira, Marlene C; Boustead, Anne E; Caulkins, Jonathan P; Kilmer, Beau; Kerr, William C; Treffers, Ryan; Naimi, Timothy S. (2022). Rating the comparative efficacy of state-level cannabis policies on recreational cannabis markets in the United States.. The International journal on drug policy, 106, 103744. https://doi.org/10.1016/j.drugpo.2022.103744
MLA
Blanchette, Jason G, et al. "Rating the comparative efficacy of state-level cannabis policies on recreational cannabis markets in the United States.." The International journal on drug policy, 2022. https://doi.org/10.1016/j.drugpo.2022.103744
RethinkTHC
RethinkTHC Research Database. "Rating the comparative efficacy of state-level cannabis poli..." RTHC-03716. Retrieved from https://rethinkthc.com/research/blanchette-2022-rating-the-comparative-efficacy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.